News

Letters: End the false economy of generic prescribing

10-Oct-08

The warning of adverse events linked to the use of generic drug alendronate in your article 'Side-effects of NICE-backed drug "wipe out cost savings"' (GP, 19 September) comes from a consultant physician.

It seems that NICE is not nice nor a patient-friendly regulatory body
any more.

The UK is adapting policy to save money at the expense of patients'
misery. Surely NICE can find a sensible alternative to this ridiculous
false economy.

GPs are all too well aware of the adverse effects patients suffer from
not only generic alendronate, but also many other cheap products pushed
into the system. The incentive scheme is a failure and it is about time
we reverted to prescribing branded, clean and well-tested pharmaceutical
products ethically.

Dr Hari Nawal, Bedford.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

Hottest Topics

Latest Topics

 
All topics

Registrar

Consultation skills - Consultations with anxious patients

Empathy and reassurance can help in consultations with anxious patients, explains Dr Mona Kular. Read more

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week